DHA phase I proposal H17A-006-0002 titled "medical device to assess the viability of tissue prior to skin grafting."

Ended Definitive Contract Awarded Last action

Contract number
W81XWH17C0170
Awardee
Awarding agency
Obligated
$149,828

Award facts

Opportunity
  • HQ003417RADST Solicitation number
Contract value 100% obligated
$149,828.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN91 R&D- Medical: Other (Basic Research)
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 39 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Dallas, TX 75201, USA
Research
STTR Phase I

Award details come from SAM.gov/FPDS.

About this award

This is a $149,828.44 Small Business Set-Aside contract awarded by the Department of the Army Medical Command to Spectral MD, Inc. for the development of a "Medical Device to Assess the Viability of Tissue Prior to Skin Grafting" under the STTR Phase I research program. The contract has a firm fixed price and was awarded on September 15, 2017, with an expected completion date of April 14, 2018. No additional subcontractors are mentioned.

Quick answers

Who was awarded contract W81XWH17C0170?

W81XWH17C0170 was awarded to Spectral MD, Inc. by Medical Command (Department of the Army) on September 15, 2017.

How much is contract W81XWH17C0170 worth?

The government has obligated $149,828 on W81XWH17C0170.

Was contract W81XWH17C0170 competed?

The extent of competition for W81XWH17C0170 was full and open competition after exclusion of sources. The government received 39 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award